Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction